Thus, our finding that defective FGF signaling contributes to caz mutant muscle phenotypes is consistent with dysregulation of the FGF pathway as a contributing factor to both FUS-ALS and SMA, further indicating that common molecular pathways may underlie FUS-ALS and SMA. Here, FUS is linked to amyotrophic lateral sclerosis.